Top

11-07-2018 | Systemic lupus erythematosus | Article

Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients

Journal: Advances in Rheumatology

Authors: Vanessa Hax, Ana Laura Didonet Moro, Rafaella Romeiro Piovesan, Luciano Zubaran Goldani, Ricardo Machado Xavier, Odirlei Andre Monticielo

Publisher: BioMed Central

Abstract

Background

Systemic lupus erythematosus (SLE) and acquired immunodeficiency syndrome (AIDS) share many clinical manifestations and laboratory findings, therefore, concomitant diagnosis of SLE and human immunodeficiency virus (HIV) can be challenging.

Methods

Prospective cohort with 602 patients with SLE who attended the Rheumatology Clinic of the Hospital de Clínicas de Porto Alegre since 2000. All patients were followed until 01 May 2015 or until death, if earlier. Demographic, clinical and laboratory data were prospectively collected.

Results

Out of the 602 patients, 11 presented with the diagnosis of AIDS (1.59%). The following variables were significantly more prevalent in patients with concomitant HIV and SLE: neuropsychiatric lupus (10.9% vs. 36.4%; p = 0.028) and smoking (37.6% vs. 80%; p = 0.0009) while malar rash was significantly less prevalent in this population (56% vs. 18.2%; p = 0.015). Nephritis (40.5% vs. 63.6%; p = 0.134) and hemolytic anemia (28.6% vs. 54.5%; p = 0.089) were more prevalent in SLE patients with HIV, but with no statistical significance compared with SLE patients without HIV. The SLICC damage index median in the last medical consultation was significantly higher in SLE patients with HIV (1 vs. 2; p = 0,047).

Conclusions

Our patients with concomitant HIV and SLE have clinically more neuropsychiatric manifestations. For the first time, according to our knowledge, higher cumulative damage was described in lupus patients with concomitant HIV infection. Further studies are needed to elucidate this complex association, its outcomes, prognosis and which therapeutic approach it’s best for each case.

Mody GM, Patel N, Budhoo A, Dubula T. Concomitant systemic lupus erythematosus and HIV: case series and literature review. Semin Arthritis Rheum. 2014;44(2):186–94.CrossRefPubMed

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRefPubMed

Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554–8.CrossRefPubMedPubMedCentral

Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.CrossRefPubMed

Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005;19(5):685–708.CrossRefPubMed

Sekigawa I, Okada M, Ogasawara H, et al. Lessons from similarities between SLE and HIV infection. J Inf Secur. 2002;44(2):67–72.

Kaye BR. Rheumatologic manifestations of HIV infections. Clin Rev Allergy Immunol. 1996;14:385–416.PubMed

Tsai WP, Nara PL, Kung HF, Oroszlan S. Inhibition of immunodeficiency virus infectivity by chloroquin. AIDS Res Hum Retrovir. 1990;6:481–9.CrossRefPubMed

Sekigawa I, Lee S, Kaneko H, et al. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus. Lupus. 2000;9:155–6.CrossRefPubMed

10.

Furie RA. Effects of human immunodeficiency virus infection on the expression of rheumatic illness. Rheum Dis Clin North Am. 1991;17:177–88.PubMed

11.

Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1(6):329–37.CrossRefPubMed

12.

Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med. 1988;84:82–8.CrossRefPubMed

13.

Medina-Rodriguez F, Guzman C, Jara LJ, et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol. 1993;20:1880–4.PubMed

14.

Petrovas C, Vlachouyiannopoulos PG, Kordossis T, Moutsopoulos M. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with B2-GPI. J Autoimmun. 1999;13:347–55.CrossRefPubMed

15.

Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LEC. Clinical implications of autoantibodies in HIV infection. AIDS. 1997;11:1845–50.CrossRefPubMed

16.

Stimmler MM, Quismorio FP Jr, McGehee WG, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:1833–5.CrossRefPubMed

17.

Muller S, Richalet P, Laurent-Crawford A, et al. Autoantibodies typical of non-organ-specific autoimmune disease in HIV-seropositive patients. AIDS. 1992;6:933–42.CrossRefPubMed

18.

Lafeuillade A, Ritter J, Pellegrino P, Qiulichini R, Monier JC. Lack of anti-nuclear antibodies during HIV infection (correspondence). AIDS. 1993;7:893.CrossRefPubMed

19.

Daikh BE, Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum. 2001;30:18–25.CrossRef

20.

Gindea S, Schwartzman J, Herlitz LC, et al. Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge. Semin Arthritis Rheum. 2010;40:201–9.CrossRefPubMed

21.

Molina JF, Citera G, Rosler D, et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol. 1995;22:347–50.PubMed

22.

Byrd VM, Sergent JS. Suppression of systemic lupus erythematosus by the human immunodeficiency virus. J Rheumatol. 1996;23:1295–6.PubMed

23.

Fox RA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum. 1997;40:1168–72.CrossRefPubMed

24.

Gould T, Tikly M. Systemic lupus erythematosus in a patient with human immunodeficiency virus infection – challenges in diagnosis and management. Clin Rheumatol. 2004;23:166–9.CrossRefPubMed

25.

López-López L, González A, Vilá LM. Long-term membranous glomerulonephritis as the presenting manifestation of systemic lupus erythematosus in a patient with human immunodeficiency virus infection. Lupus. 2012;21:900–4.CrossRefPubMed

26.

Gul A, Inanc M, Yilmaz G, et al. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus. Lupus. 1996;5:120–2.CrossRefPubMed

27.

UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance 2001 Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation. Available at http://www.who.int/hiv/pub/epidemiology/pub4/en/.

28.

Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retrovir. 1993;9:91–8.CrossRefPubMed

29.

Sperber K, Ornstein MH. The anti-inflammatory effect of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis and Rheum. 1996;39:157–61.CrossRef

30.

Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003;76:370–5.CrossRefPubMed

31.

World Health Organization. TB/HIV Facts. Factsheet. Geneva: World Health Organization; 2013. Available at http://www.who.int/tb/challenges/hiv/factsheets/en

32.

Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38:473–85.CrossRefPubMed